U19NS132304
Cooperative Agreement
Overview
Grant Description
Preclinical genome editing for rare neurological diseases.
Awardee
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Place of Performance
Bar Harbor,
Maine
04609
United States
Geographic Scope
Single Zip Code
Related Opportunity
Analysis Notes
Amendment Since initial award the total obligations have increased 201% from $4,247,547 to $12,795,256.
Jackson Laboratory was awarded
Preclinical Genome Editing for Rare Neurological Diseases
Cooperative Agreement U19NS132304
worth $12,795,256
from the National Institute of Allergy and Infectious Diseases in May 2023 with work to be completed primarily in Bar Harbor Maine United States.
The grant
has a duration of 5 years and
was awarded through assistance program 93.310 Trans-NIH Research Support.
The Cooperative Agreement was awarded through grant opportunity IND-enabling Studies of Somatic Genome Editing Therapeutic Leads (U19, Clinical Trial Not allowed).
Status
(Ongoing)
Last Modified 5/5/25
Period of Performance
5/16/23
Start Date
4/30/28
End Date
Funding Split
$12.8M
Federal Obligation
$0.0
Non-Federal Obligation
$12.8M
Total Obligated
Activity Timeline
Subgrant Awards
Disclosed subgrants for U19NS132304
Transaction History
Modifications to U19NS132304
Additional Detail
Award ID FAIN
U19NS132304
SAI Number
U19NS132304-467978833
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Nonprofit With 501(c)(3) IRS Status (Other Than An Institution Of Higher Education)
Awarding Office
75NQ00 NIH National Institute of Neurological Disorders and Stroke
Funding Office
75NA00 NIH OFFICE OF THE DIRECTOR
Awardee UEI
XR6LMXNKDJJ1
Awardee CAGE
9N885
Performance District
ME-02
Senators
Susan Collins
Angus King
Angus King
Budget Funding
Federal Account | Budget Subfunction | Object Class | Total | Percentage |
---|---|---|---|---|
Office of the Director, National Institutes of Health, Health and Human Services (075-0846) | Health research and training | Grants, subsidies, and contributions (41.0) | $4,262,002 | 100% |
Modified: 5/5/25